Debiopharm Innovation Fund S.A.

investing in

We are the strategic investment fund of the Group

Investment focus is Smart Data & Digital Health in oncology and infectious disease, with an impact on drug development and the patient journey

Company stage
Late pilot or early commercial
Investment round
Series A and B
Our initial investment
$1M - 10M
Startup funding
Latest news
February 15, 2019

Largest private hospital in SE Asia, Bumrungrad International, partners with BC Platforms

Read more
February 11, 2019

BARDA grant awarded to Immunexpress to support development of Septicyte test for Sepsis Diagnosis

Read more
See all news
Let's meet

Wired Health Conference 2019

March 27, 2019 London, UK Discover
See all events


Discover our Portfolio

Our current and past investments


At a glance

Our mission

Debiopharm Innovation Fund’s objective is to make strategic investments in innovative companies with technologies and business models that change the way we develop drugs and treat patients.

We bring value to our portfolio companies through our knowledge in medicine, pharmaceutical development, regulatory/reimbursement aspects, management and expertise in bringing products to market. We drive our portfolio investments to successful exits.

Our objectives

  • 2-3 new investments per year
  • Active involvement to help portfolio companies develop
  • Long term value creation

Our investment criteria

  • Strong management team
  • Ambitious vision
  • Innovative technology
  • Robust execution plan


  • Over 100 million invested since 2008
  • Cumulative equity raised by all companies: USD 500 million
  • We led 12 out of the 15 last investment rounds
  • Portfolio company achievements: 18 FDA clearances or CE marks, 2 IPOs
CEO of Debiopharm Innovation Fund S.A.

Discover the people who guide and bring long-term vision to the company

Contact us

Would like to work with us? Got a question or a comment? Get in touch!